Wolverine: uses, dosing & the facts

A foundational injury recovery peptide blend combining BPC-157 and TB-500. Designed for aggressive soft tissue repair, tendon and ligament healing, and post-surgery recovery. The combination provides synergistic healing effects for acute injuries and high-severity tissue damage. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.

By OptiPin Editorial·Last updated July 2026

Status

Research use only · not FDA-approved. Reported dosing below reflects community-discussed patterns, presented for information only — not a dose recommendation. For the US regulatory picture on research peptides, see the 2026 FDA compounding status.

Class

Research peptide

Used for

Soft tissue repair and regeneration

Half-life

BPC-157: 4-6 hours. …

Status

Research use only

TL;DR

• Wolverine — Research peptide. A foundational injury recovery peptide blend combining BPC-157 and TB-500.
• Commonly used for soft tissue repair and regeneration, tendon and ligament healing, post-surgery recovery.
• Half-life: BPC-157: 4-6 hours. TB-500: 2-3 hours. Combined effects provide sustained healing throughout the day..
• Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.

What Wolverine is

What Wolverine is used for

• Soft tissue repair and regeneration
• Tendon and ligament healing
• Post-surgery recovery
• Acute injury recovery
• High-severity tissue damage repair
• Muscle and joint injury healing

These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.

Typical reported dosing

Injectable

Standard: 500mcg each BPC-157 and TB-500 daily subcutaneously. Aggressive protocols: 1-2mg BPC-157 and 2mg TB-500 daily for 3+ months. Typical blend: 5mg BPC-157 + 5mg TB-500 per vial.

Presented as commonly-reported patterns for information only — not a dose recommendation. Wolverine dosing is a decision for a qualified clinician.

Reconstitution

Reconstitute blend vial with 2mL bacteriostatic water. Standard dose (500mcg each) = varies by vial concentration. Check individual component reconstitution guides. The arithmetic is the same for any peptide: concentration = vial mg ÷ water mL, and on a U-100 syringe 100 units = 1 mL. Compute your own vial with the reconstitution calculator.

Half-life & cycling

Half-life: BPC-157: 4-6 hours. TB-500: 2-3 hours. Combined effects provide sustained healing throughout the day.. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.

Cycling

Used for injury recovery: typically 4-8 weeks for acute injuries, up to 3+ months for severe damage. Visible improvements in pain reduction within 7-10 days; full recovery typically 6-8 weeks. Can be cycled as needed for injuries.

Side effects & warnings

• Generally well-tolerated
• Mild injection site irritation possible
• Minimal side effects when used appropriately

Research use only. The foundational injury recovery stack. Most effective for acute injuries and high-severity damage. Aggressive protocols require longer commitment (3+ months). Consult with healthcare provider before use. Synergistic effects make this combination more effective than individual peptides alone.

Not a prescription, a dose, or a sourcing guide. Wolverine is a research compound; safety and efficacy in humans are not fully established, and research-grade material has no guarantee of purity, sterility, or stated strength. OptiPin is a tracking tool and does not recommend using research chemicals. Discuss any peptide with a qualified clinician.

Tracking Wolverine in OptiPin

If you're tracking a Wolverine protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.

Track it properly

Log doses, outcomes & vials in OptiPin

Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.

Download on the App Store

FAQ

What is Wolverine?

What is Wolverine used for?

Commonly discussed uses include: soft tissue repair and regeneration, tendon and ligament healing, post-surgery recovery, acute injury recovery, high-severity tissue damage repair, muscle and joint injury healing. These are reported uses, not proven outcomes or a recommendation.

How is Wolverine dosed?

Commonly reported dosing: Injectable — Standard: 500mcg each BPC-157 and TB-500 daily subcutaneously. Aggressive protocols: 1-2mg BPC-157 and 2mg TB-500 daily for 3+ months. Typical blend: 5mg BPC-157 + 5mg TB-500 per vial.. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — Wolverine is not an approved medicine and dosing should involve a qualified clinician.

How do you reconstitute Wolverine?

Reconstitute blend vial with 2mL bacteriostatic water. Standard dose (500mcg each) = varies by vial concentration. Check individual component reconstitution guides. On a U-100 syringe, 100 units = 1 mL. Concentrations vary by vial, so compute from your own vial with a reconstitution calculator.

What is Wolverine's half-life?

BPC-157: 4-6 hours. TB-500: 2-3 hours. Combined effects provide sustained healing throughout the day.. Half-life shapes how often it is dosed and how quickly it clears.

What are Wolverine's side effects?

Reported effects include: generally well-tolerated, mild injection site irritation possible, minimal side effects when used appropriately. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.

Educational only, not medical advice. Wolverine is a research compound and is not an approved medicine for the uses described. OptiPin is a tracking tool and does not provide dosing or treatment advice. Discuss any peptide with a qualified clinician.

Evidence & further reading

Search the peer-reviewed literature for Wolverine on PubMed (entry point to the primary evidence base, not a specific citation).
Wolverine on ClinicalTrials.gov — registered human trials, if any.
US FDA / 503A compounding status of research peptides (2026).
OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.

Actovegin · ARA-290 · CJC-1295 (with DAC) · CJC-1295 (without DAC) · BPC-157 · TB-500 · Reconstitution calculator · All peptides